A mixed methods pilot and feasibility open trial of internet-delivered cognitive behaviour therapy (iCanADAPT Advanced) for people with advanced cancer with depression and/or anxiety

Murphy, Michael J.; Newby, Jill M.; Butow, Phyllis; Joubert, Amy E.; Kirsten, Laura; Shaw, Joanne; Shepherd, Heather L.; Andrews, Gavin

doi:10.1016/j.invent.2021.100449

Cited by 7 publications

(9 citation statements)

References 67 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…57 iCanADAPT is a further online intervention that can help mitigate FCR among patients with both early-stage cancer or metastatic disease. 58,59 This intervention consists of six to eight modules, depending on the disease stage, called lessons (e.g., depression and anxiety, adjusting to change, identifying thoughts, unhelpful behaviors, facing fears) that help guide patients in the development of various coping mechanisms. Furthermore, a smartphone app-based mindfulness program has also shown positive results with regard to FCR symptoms over time.…”

Section: Treatment Interventions For Fcrmentioning

confidence: 99%

Fear of Cancer Recurrence or Progression: What Is It and What Can We Do About It?

Bergerot¹,

Philip

Bergerot³

et al. 2022

American Society of Clinical Oncology Educational Book

View full text Add to dashboard Cite

Patients with cancer face a trajectory marked by emotional and physical distress that can be associated with both diagnosis and treatment. Fear of cancer recurrence or progression has been considered one of the most common unmet needs reported by patients diagnosed with both localized and metastatic disease. Fear of cancer recurrence or progression has been defined as the “fear, worry, or concern relating to the possibility that cancer will come back or progress.” Often overlooked by health care teams, fear of cancer recurrence or progression has been associated with impaired quality of life and psychosocial adjustment, elevated emotional distress, and a range of physical symptoms. Several interventions for fear of cancer recurrence or progression are currently under investigation. Early recognition, support, and validation of feelings associated with fear of cancer recurrence or progression, and appropriate referrals to psychosocial oncology, can be beneficial for many patients. Assessing patients early in their cancer trajectory, and at important milestones, including a change in therapies, at the end of active treatment, and during follow-up visits, can help identify individuals at risk and help individuals engage in supportive programs.

show abstract

Section: Treatment Interventions For Fcrmentioning

confidence: 99%

Fear of Cancer Recurrence or Progression: What Is It and What Can We Do About It?

Bergerot¹,

Philip

Bergerot³

et al. 2022

American Society of Clinical Oncology Educational Book

View full text Add to dashboard Cite

show abstract

“…They included mainly female patients and are heterogeneous in terms of disease characteristics, therapeutic aims of interventions, techniques, and outcome measures (Table 1). The interventions described were for patients with prostate cancer [30,38], breast cancer [33,35], and melanoma [39 ▪▪ ], as well as those with mixed diagnoses [29,31,32,34,36,37,40 ▪▪ ,41 ▪▪ ,42 ▪ ]. Times since metastatic diagnosis ranged from less than 1 year [31,40 ▪▪ ] to 6 years [30,37].…”

Section: Overview Of Psychological Interventions For Patients With Me...mentioning

confidence: 99%

“…The intervention modalities are summarized in Table 2. The interventions were individual [29,31,36,37,39 ▪▪ ,40 ▪▪ ,41 ▪▪ ] and dyadic [32], self-administered online [31,40 ▪▪ ] and delivered in person [36,37] or by telephone [32], or with mixed formats [41 ▪▪ ]. The numbers of weekly sessions ranged from one [36] to eight [29], and session durations ranged from 20 [31] to 90 min [37,39 ▪▪ ].…”

Section: Interventions Addressing Moderate or High Levels Of Psycholo...mentioning

confidence: 99%

“…The interventions described were for patients with prostate cancer [30,38], breast cancer [33,35], and melanoma [39 ▪▪ ], as well as those with mixed diagnoses [29,31,32,34,36,37,40 ▪▪ ,41 ▪▪ ,42 ▪ ]. Times since metastatic diagnosis ranged from less than 1 year [31,40 ▪▪ ] to 6 years [30,37]. Two main therapeutic aims were identified; one group of interventions was intended to promote the adaptation of all patients with metastatic cancer [30,33–35,38,42 ▪ ,43], and the other targeted patients experiencing moderate-to-high levels of psychological distress [29,31,32,36,37,39 ▪▪ ,40 ▪▪ ,41 ▪▪ ].…”

Section: Overview Of Psychological Interventions For Patients With Me...mentioning

confidence: 99%

“…Times since metastatic diagnosis ranged from less than 1 year [31,40 ▪▪ ] to 6 years [30,37]. Two main therapeutic aims were identified; one group of interventions was intended to promote the adaptation of all patients with metastatic cancer [30,33–35,38,42 ▪ ,43], and the other targeted patients experiencing moderate-to-high levels of psychological distress [29,31,32,36,37,39 ▪▪ ,40 ▪▪ ,41 ▪▪ ].…”

Section: Overview Of Psychological Interventions For Patients With Me...mentioning

confidence: 99%

See 2 more Smart Citations

Psychological interventions targeting patients with metastatic cancer and prolonged survival expectancies: advances and challenges

Righes

Waroquier

et al. 2022

Current Opinion in Oncology

View full text Add to dashboard Cite

Purpose of reviewThe purpose of this article is to review the formats and techniques of psychological interventions designed for patients with metastatic cancer and prolonged survival expectancies.Recent findingsFifteen interventional studies were selected for this article. One group of psychological interventions focused primarily on patients’ adaptation by increasing their knowledge, developing patients’ stress management skills, promoting their open communication with healthcare providers, and helping them deal with existential concerns. Another group of interventions focused on patients with moderate and high levels of distress. These interventions provided specific techniques to manage anxiety, depression, fear of cancer progression, and existential distress. Interestingly, interventions targeting distressed patients are not necessarily longer or more intensive than interventions targeting adaptation. The interventions were examined in few randomized controlled trials, and incorporated a broad range of techniques, making comparison of their efficacy difficult. No intervention specifically targeted patients newly diagnosed with metastatic cancer.SummaryOn the basis of this review, we proposed suggestions according to patients’ levels of distress, which differ in intensity, format, techniques, and tools offered. These suggestions may be relevant for the future development and assessment of interventions targeting patients with newly diagnosed metastatic cancer and prolonged survival expectancies.

show abstract

Living well with advanced cancer: a scoping review of non-pharmacological supportive care interventions

Kumar,

Htaa,

Kerin-Ayres

et al. 2024

J Cancer Surviv

View full text Add to dashboard Cite

Purpose The increasing number of people living longer with advanced cancer presents unique physical, psychosocial, financial, legal, practical and complex care needs. Supportive care interventions aim to address these needs by improving symptom management, promoting wellbeing, enhancing quality of life and potentially improving prognosis. To integrate supportive care interventions into clinical practice, a comprehensive review of existing studies is needed. This scoping review maps the evidence on non-pharmacological supportive care interventions for people with advanced cancer and identifies gaps to inform future research. Methods We systematically searched four electronic databases—CINAHL, Medline, Cochrane and PsycINFO—for peer-reviewed original research on non-pharmacological supportive care interventions for adults with advanced cancer, published from January 1, 2013, to July 1, 2024. Results Out of 3716 studies, 84 publications met the inclusion criteria. These studies were categorised into key supportive care domains: physical activity, psychosocial support, patient care and autonomy, multimodal approaches and others. Most publications focused on interventions addressing physical and psychosocial needs, showing benefits such as reduced fatigue, pain and improved mood. However, significant gaps were found in research on interventions addressing practical needs essential to autonomy, including health system and information needs, patient care and support and financial needs. Conclusion Mapping the studies to the needs of the advanced cancer population showed that domains with greatest unmet needs have the fewest interventions available. Our scoping review suggests that non-pharmacological supportive care interventions can improve the wellbeing and quality of life of people living with advanced cancer. However, addressing methodological limitations requires further large-scale, multi-centre studies focusing on the identified gaps to inform the implementation of suitable supportive care programs. Implications for Cancer Survivors Non-pharmacological interventions can boost wellbeing and quality of life for advanced cancer survivors, but addressing gaps in practical and systemic support is crucial.

show abstract

A mixed methods pilot and feasibility open trial of internet-delivered cognitive behaviour therapy (iCanADAPT Advanced) for people with advanced cancer with depression and/or anxiety

Cited by 7 publications

References 67 publications

Fear of Cancer Recurrence or Progression: What Is It and What Can We Do About It?

Fear of Cancer Recurrence or Progression: What Is It and What Can We Do About It?

Psychological interventions targeting patients with metastatic cancer and prolonged survival expectancies: advances and challenges

Living well with advanced cancer: a scoping review of non-pharmacological supportive care interventions

Contact Info

Product

Resources

About